COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective.

ABSTRACT:

Introduction

The side effects of systemic cancer therapy and the lack of clinical data on safety and efficacy of COVID-19 vaccination in cancer patients cause uncertainty among the patients about whether to get vaccinated or not. Here, we evaluated attitude towards and effects of COVID-19 vaccination in patients with breast and gynecological cancer undergoing systemic cancer therapy.

Methods

Since March 15th, 2021, cancer patients who received one of the approved COVID-19 vaccines were routinely interviewed about immediate and late side effects. Clinical parameters such as current therapy, time interval between therapy administration and vaccination, and changes in the therapy schedule due to vaccination were documented. The collected data were analyzed de-identified as a pa

SUBMITTER: Forster M 

PROVIDER: S-EPMC8555340 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature